Influenza vaccine effectiveness against hospitalisation with influenza in adults in Australia in 2014

被引:19
作者
Cheng, Allen C. [1 ,2 ]
Kotsimbos, Tom [3 ,4 ]
Kelly, Paul M. [5 ]
机构
[1] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia
[2] Alfred Hlth, Infect Prevent & Healthcare Epidemiol Unit, Melbourne, Australia
[3] Alfred Hlth, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia
[4] Monash Univ, Melbourne, Vic 3004, Australia
[5] ACT Hlth Directorate, Canberra, ACT, Australia
关键词
Influenza vaccination; Test negative design; Vaccine effectiveness; Hospitalisation; RARE DISEASE ASSUMPTION; COMMON DISEASES; EFFICACY; VALIDITY;
D O I
10.1016/j.vaccine.2015.10.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We provide estimates of the influenza vaccine protection against hospitalisation with laboratory-confirmed influenza in the 2014 Australian season where the A/H1N1/pdm09 strain predominated. This was performed using a case-test negative study design as part of a national sentinel surveillance system in Australia. Vaccine effectiveness was estimated as (1-OR) x 100% where the odds ratio of vaccination in cases vs test negative participants was estimated from a conditional logistic regression. Between April and November, 1692 adult patients were admitted with laboratory-confirmed influenza. Vaccine effectiveness was estimated from 1283 patients with influenza and 1116 test negative patients where vaccination status was ascertained. Vaccination was associated with a reduction in the risk of hospitalisation with influenza of 51.5% (95% CI: 41.6%, 59.7%) in all patients, and a reduction of 50.7% (95% CI: 40.1%, 59.3%) in the target population for vaccination. We estimate that the influenza vaccine was moderately protective against hospitalisation with laboratory-confirmed influenza during the 2014 influenza season in Australia. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:7352 / 7356
页数:5
相关论文
共 27 条
[1]  
[Anonymous], EUR SURVEILL
[2]  
[Anonymous], EUR SURVEILL
[3]  
[Anonymous], 2014, REC COMP INFL VIR VA
[4]  
[Anonymous], EUR SURVEILL
[5]  
[Anonymous], 2013, Recommended composition of influenza virus vaccines for use in the 2013-2014 northern hemisphere influenza season
[6]  
[Anonymous], 0827 AUSTR DEP HLTH
[7]  
*ATAGI, 2013, AUSTR IMM HDB
[8]  
Cheng AC, 2014, COMMUN DIS INTELL, V38, pE143
[9]   Influenza Vaccine Effectiveness against Hospitalisation with Confirmed Influenza in the 2010-11 Seasons: A Test-negative Observational Study [J].
Cheng, Allen C. ;
Holmes, Mark ;
Irving, Louis B. ;
Brown, Simon G. A. ;
Waterer, Grant W. ;
Korman, Tony M. ;
Friedman, N. Deborah ;
Senanayake, Sanjaya ;
Dwyer, Dominic E. ;
Brady, Stephen ;
Simpson, Grahame ;
Wood-Baker, Richard ;
Upham, John ;
Paterson, David ;
Jenkins, Christine ;
Wark, Peter ;
Kelly, Paul M. ;
Kotsimbos, Tom .
PLOS ONE, 2013, 8 (07)
[10]   Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: A test-negative case control study [J].
Cheng, Allen C. ;
Kotsimbos, Tom ;
Kelly, Heath A. ;
Irving, Louis B. ;
Bowler, Simon D. ;
Brown, Simon G. A. ;
Holmes, Mark ;
Jenkins, Christine R. ;
Thompson, Philip ;
Simpson, Graham ;
Wood-Baker, Richard ;
Senanayake, Sanjaya N. ;
Brady, Stephen J. ;
Paterson, David L. ;
Wark, Peter A. ;
Upham, John W. ;
Korman, Tony M. ;
Dwyer, Dominic E. ;
Waterer, Grant W. ;
Kelly, Paul M. .
VACCINE, 2011, 29 (43) :7320-7325